BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37748967)

  • 1. Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres.
    Schwameis R; Fanfani F; Ebner C; Zimmermann N; Peters I; Nero C; Marth C; Ristl R; Leitner K; Grimm C; Oberndorfer F; Capasso I; Zeimet AG; Polterauer S; Scambia G; Fagotti A; Concin N
    Eur J Cancer; 2023 Nov; 193():113317. PubMed ID: 37748967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial cancer risk factors, treatment, and survival outcomes as per the European Society for Medical Oncology (ESMO) - European Society of Gynaecological Oncology (ESGO) - European Society for Radiotherapy and Oncology (ESTRO) risk groups and International Federation of Gynecology and Obstetrics (FIGO) staging: An experience from developing world.
    Gupta N; Pandey A; Dimri K; Sehgal A; Bhagat R; Suraj ; Gill G
    J Cancer Res Ther; 2023; 19(3):701-707. PubMed ID: 37470597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FIGO staging of endometrial cancer: 2023.
    Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
    Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new 2023 FIGO staging system for endometrial cancer: what is different from the previous 2009 FIGO staging system?
    Han KH; Park N; Lee M; Lee C; Kim H
    J Gynecol Oncol; 2024 Jan; ():. PubMed ID: 38302727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic performance of the 2023 FIGO staging schema for endometrial cancer.
    Matsuo K; Chen L; Klar M; Lee MW; Machida H; Mikami M; Muderspach LI; Carlson JW; Roman LD; Wright JD
    Gynecol Oncol; 2024 May; 187():37-45. PubMed ID: 38713997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort.
    Vengaloor Thomas T; Reddy KK; Gandhi S; Nittala MR; Abraham A; Robinson W; Ridgway M; Packianathan S; Vijayakumar S
    Cureus; 2021 Nov; 13(11):e19289. PubMed ID: 34877225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
    Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.
    Zivanovic O; Leitao MM; Iasonos A; Jacks LM; Zhou Q; Abu-Rustum NR; Soslow RA; Juretzka MM; Chi DS; Barakat RR; Brennan MF; Hensley ML
    J Clin Oncol; 2009 Apr; 27(12):2066-72. PubMed ID: 19255317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma.
    Raut CP; Nucci MR; Wang Q; Manola J; Bertagnolli MM; Demetri GD; Morgan JA; Muto MG; Fletcher CD; George S
    Eur J Cancer; 2009 Nov; 45(16):2818-24. PubMed ID: 19647426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?
    Abu-Rustum NR; Zhou Q; Iasonos A; Alektiar KM; Leitao MM; Chi DS; Sonoda Y; Soslow R; Hensley M; Barakat RR
    Int J Gynecol Cancer; 2011 Apr; 21(3):511-6. PubMed ID: 21436699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Analysis and Comparison of the 2014 and 2018 International Federation of Gynecology and Obstetrics Staging System on Overall Survival in Patients with Stage IIB-IVA Cervix Carcinoma.
    Song T; Xu H; Shi L; Yan S
    Int J Womens Health; 2022; 14():333-344. PubMed ID: 35283649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
    Cooke EW; Pappas L; Gaffney DK
    Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy for advanced endometrial cancer.
    Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revaluating the survival effects of International Federation of Gynecology and Obstetrics 1988 stage IIIA criteria for endometrial cancer.
    Türkmen O; Karalok A; Başaran D; Kimyon G; Kul G; Tulunay G; Üreyen I; Turan T
    J Turk Ger Gynecol Assoc; 2017 Sep; 18(3):110-115. PubMed ID: 28890424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FIGO 2023 endometrial cancer staging: too much, too soon?
    McCluggage WG; Bosse T; Gilks CB; Howitt BE; McAlpine JN; Nucci MR; Rabban JT; Singh N; Talia KL; Parra-Herran C
    Int J Gynecol Cancer; 2023 Nov; ():. PubMed ID: 37935523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors.
    Yan DD; Tang Q; Chen JH; Tu YQ; Lv XJ
    Cancer Manag Res; 2019; 11():5473-5480. PubMed ID: 31354353
    [No Abstract]   [Full Text] [Related]  

  • 19. FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype.
    Haltia UM; Bützow R; Leminen A; Loukovaara M
    J Gynecol Oncol; 2014 Jan; 25(1):30-5. PubMed ID: 24459578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphadenectomy increases the prognostic value of the revised 2009 FIGO staging system for endometrial cancer: a multi-center study.
    Kim HS; Kim HY; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW
    Eur J Surg Oncol; 2012 Mar; 38(3):230-7. PubMed ID: 22244682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.